Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H35NO2 |
| Molecular Weight | 321.4974 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(OCCN1CCCCC1)C2(CCCCC2)C3CCCCC3
InChI
InChIKey=MNSQDVCVWNXBFQ-UHFFFAOYSA-N
InChI=1S/C20H35NO2/c22-19(23-17-16-21-14-8-3-9-15-21)20(12-6-2-7-13-20)18-10-4-1-5-11-18/h18H,1-17H2
| Molecular Formula | C20H35NO2 |
| Molecular Weight | 321.4974 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dihexyverine (Metaspas, Spasmodex) is an anticholinergic and direct smooth muscle relaxant (spasmolytic). Dihexyverine is sold in France under the brand name Spasmodex. It is indicated for the treatment of the gastrointestinal tract disorders. Dihexyverine is a muscarinic acetylcholine receptor antagonist.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/13944939
One hundred and five patients constituted the series: 31 were primiparae, 27 secundiparae and 47 multiparae. The majority of these (95) received one intramuscular injection (10 mg) of dihexyverine.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:08:10 GMT 2025
by
admin
on
Mon Mar 31 19:08:10 GMT 2025
|
| Record UNII |
J2FQ66RU9W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
||
|
NCI_THESAURUS |
C29698
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
||
|
WHO-VATC |
QA03AA08
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
||
|
WHO-ATC |
A03AA08
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m1114
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB07136MIG
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
236209
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | RxNorm | ||
|
561-77-3
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
C97978
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110912
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
DTXSID80204645
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
DIHEXYVERINE
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
361
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
883
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
100000082605
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
DB13678
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
J2FQ66RU9W
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY | |||
|
21788
Created by
admin on Mon Mar 31 19:08:10 GMT 2025 , Edited by admin on Mon Mar 31 19:08:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |